Mouse embryonic stem cells are hypersensitive to apoptosis triggered by the DNA damage O6-methylguanine due to high E2F1 regulated mismatch repair

被引:62
作者
Roos, W. P.
Christmann, M.
Fraser, S. T.
Kaina, B.
机构
[1] Johannes Gutenberg Univ Mainz, Dept Toxicol, D-55131 Mainz, Germany
[2] CUNY Mt Sinai Sch Med, New York, NY 10029 USA
关键词
apoptosis; embryonic stem cells; MGMT; mismatch repair; DNA damage;
D O I
10.1038/sj.cdd.4402136
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Exposure of stem cells to genotoxins may lead to embryonic lethality or teratogenic effects. This can be prevented by efficient DNA repair or by eliminating genetically damaged cells. Using undifferentiated mouse embryonic stem (ES) cells as a pluripotent model system, we compared ES cells with differentiated cells, with regard to apoptosis induction by alkylating agents forming the highly mutagenic and killing DNA adduct O-6-methylguanine. Upon treatment with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), ES cells undergo apoptosis at much higher frequency than differentiated cells, although they express a high level of the repair protein O-6-methylguanine-DNA methyltransferase (MGMT). Apoptosis induced by MNNG is due to O-6-methylguanine DNA adducts, since inhibition of MGMT sensitized ES cells. The high sensitivity of ES cells to O-6-methylating agents is due to high expression of the mismatch repair proteins MSH2 and MSH6 (MutS alpha), which declines during differentiation. High MutS alpha expression in ES cells was related to a high hyperphosphorylated retinoblastoma (ppRb) level and E2F1 activity that upregulates MSH2, causing, in turn, stabilization of MSH6. Non-repaired O-6-methylguanine adducts were shown to cause DNA double-stranded breaks, stabilization of p53 and upregulation of Fas/CD95/Apo-1 at significantly higher level in ES cells than in fibroblasts. The high apoptotic response of ES cells to O-6-methylguanine adducts may contribute to reduction of the mutational load in the progenitor population.
引用
收藏
页码:1422 / 1432
页数:11
相关论文
共 40 条
[1]   Inhibition of Bax channel-forming activity by Bcl-2 [J].
Antonsson, B ;
Conti, F ;
Ciavatta, A ;
Montessuit, S ;
Lewis, S ;
Martinou, I ;
Bernasconi, L ;
Bernard, A ;
Mermod, JJ ;
Mazzei, G ;
Maundrell, K ;
Gambale, F ;
Sadoul, R ;
Martinou, JC .
SCIENCE, 1997, 277 (5324) :370-372
[2]   GENETIC CONSEQUENCES OF TOLERANCE TO METHYLATION DNA-DAMAGE IN MAMMALIAN-CELLS [J].
AQUILINA, G ;
BIONDO, R ;
DOGLIOTTI, E ;
BIGNAMI, M .
CARCINOGENESIS, 1993, 14 (10) :2097-2103
[3]  
Becker K, 1996, CANCER RES, V56, P3244
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   Processing of O-6-methylguanine by mismatch correction in human cell extracts [J].
Ceccotti, S ;
Aquilina, G ;
Macpherson, P ;
Yamada, M ;
Karran, P ;
Bignami, M .
CURRENT BIOLOGY, 1996, 6 (11) :1528-1531
[6]   Embryonic stem cells and somatic cells differ in mutation frequency and type [J].
Cervantes, RB ;
Stringer, JR ;
Shao, CS ;
Tischfield, JA ;
Stambrook, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) :3586-3590
[7]   Steady-state regulation of the human DNA mismatch repair system [J].
Chang, DK ;
Ricciardiello, L ;
Goel, A ;
Chang, CL ;
Boland, CR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (24) :18424-18431
[8]   Msh2 deficiency does not contribute to cisplatin resistance in mouse embryonic stem cells [J].
Claij, N ;
Riele, HT .
ONCOGENE, 2004, 23 (01) :260-266
[9]   Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level [J].
Claij, N ;
Riele, HT .
ONCOGENE, 2002, 21 (18) :2873-2879
[10]   INACTIVATION OF THE MOUSE MSH2 GENE RESULTS IN MISMATCH REPAIR DEFICIENCY, METHYLATION TOLERANCE, HYPERRECOMBINATION, AND PREDISPOSITION TO CANCER [J].
DEWIND, N ;
DEKKER, M ;
BERNS, A ;
RADMAN, M ;
RIELE, HT .
CELL, 1995, 82 (02) :321-330